LONDON, ONTARIO--(MARKET WIRE)--Aug 14, 2007 -- Stellar Pharmaceuticals Inc., (CDNX:SLX.V - News)(OTC BB:SLXCF.OB - News) (“Stellar”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it plans to release its 2007 second quarter financial results prior to the opening of the stock market on Wednesday, August 15, 2007. Management will conduct a conference call that morning at 11:00 a.m. Eastern Time to discuss these results. Interested parties may participate in the call by dialing 866-542-4238 (in the United States) or 416-641-6125 (in Canada) approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Stellar Pharmaceuticals Conference Call.
